September 2021
237 articles-
Sep 30 · 10:45Biotechnology Daily
FDA clears Paige's AI as first program to spot prostate cancer in tissue slides
-
Sep 30 · 10:42Biotechnology Daily
Summit Clinical Research, PathAI partner on clinical trial services for NASH treatments
-
Sep 30 · 10:41Biotechnology Daily
Velocity Clinical Research acquires 11 sites through 2 companies months after its own buyout
-
Sep 30 · 10:35Biotechnology Daily
Know Labs unveils pocket-sized glucose monitor that swaps fingersticks for radiofrequency sensors
-
Sep 30 · 10:33Bio Business News
Castor, Trialbee team up for patient enrollment, engagement in clinical trials
-
Sep 30 · 10:29Bio Business News
HealthVerity partners with J&J's Janssen to provide real-world data for clinical trial, R&D work
-
Sep 30 · 10:18Bio Business News
Facing backlash from scientific community, Cassava drops interim Alzheimer's data with plenty of caveats
-
Sep 30 · 10:14Bio Business News
Fungi funding: Hexagon Bio snags $61M to test drugs from fungi for cancer, infectious diseases
-
Sep 30 · 09:50Market Watch
Warby Parker shares soar 34% in trading debut
-
Sep 30 · 09:47Market Watch
Made Tech Group Shares Rise on Stock Market Debut
-
Sep 30 · 09:45Market Watch
Meme traders see red as heavily-shorted stocks grow scarcer and old names fall
-
Sep 28 · 23:21Biotechnology Daily
Apple taps Biogen, UCLA to explore adding mental health tracking to iPhone: report
-
Sep 28 · 23:19Biotechnology Daily
Aerie CEO exits days after downplaying midphase eye disease flop
-
Sep 28 · 23:18Biotechnology Daily
Bristol Myers, Genentech and Celgene bought their old biotechs. Stafford and co. are ready for their next $60M act
-
Sep 28 · 23:17Biotechnology Daily
The immune system 'goes rogue' after a stroke, but new research has found a way to block the pathway in mice
-
Sep 28 · 23:15Bio Business News
European antitrust regulator delivers ultimatum to Illumina over $8B Grail deal
-
Sep 28 · 23:03Bio Business News
Striking deals with Blueprint COO Haviland
-
Sep 28 · 23:01Bio Business News
Boehringer Ingelheim acquires Abexxa Biologics for precision cancer drug pipeline
-
Sep 28 · 22:59Bio Business News
Luxturna inventor's research helps seal gene therapy biotech Opus Genetics' $19M debut
-
Sep 28 · 22:45Market Watch
Bank of Montreal stock outperforms market despite losses on the day
-
Sep 28 · 22:44Market Watch
Jefferies lifts financial stock rating to overweight from
-
Sep 28 · 22:39Market Watch
Hair products maker Olaplex boosts IPO price ahead of debut
-
Sep 28 · 06:16Biotechnology Daily
ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise
-
Sep 28 · 06:15Biotechnology Daily
Johnson & Johnson, Mauna Kea launch study of lung cancer biopsy guidance tool